2,790 Shares in Intuitive Surgical, Inc. (NASDAQ:ISRG) Purchased by Crestline Management LP

Crestline Management LP bought a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 2,790 shares of the medical equipment provider's stock, valued at approximately $1,456,000.

Several other institutional investors have also made changes to their positions in the company. Vanguard Group Inc. raised its stake in shares of Intuitive Surgical by 1.1% in the 4th quarter. Vanguard Group Inc. now owns 32,212,196 shares of the medical equipment provider's stock valued at $16,813,478,000 after buying an additional 360,591 shares in the last quarter. Geode Capital Management LLC boosted its stake in Intuitive Surgical by 3.2% in the 4th quarter. Geode Capital Management LLC now owns 7,756,727 shares of the medical equipment provider's stock worth $4,039,200,000 after purchasing an additional 243,802 shares during the period. Fisher Asset Management LLC grew its position in Intuitive Surgical by 1.8% in the fourth quarter. Fisher Asset Management LLC now owns 4,868,869 shares of the medical equipment provider's stock valued at $2,541,356,000 after purchasing an additional 86,488 shares in the last quarter. Norges Bank acquired a new stake in shares of Intuitive Surgical in the 4th quarter valued at approximately $2,401,493,000. Finally, Invesco Ltd. lifted its holdings in Intuitive Surgical by 7.7% during the 4th quarter. Invesco Ltd. now owns 4,148,180 shares of the medical equipment provider's stock valued at $2,165,184,000 after purchasing an additional 295,025 shares during the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other news, CFO Jamie Samath sold 188 shares of Intuitive Surgical stock in a transaction dated Friday, February 28th. The shares were sold at an average price of $566.94, for a total value of $106,584.72. Following the completion of the transaction, the chief financial officer now directly owns 7,162 shares of the company's stock, valued at approximately $4,060,424.28. The trade was a 2.56% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Jami K. Nachtsheim sold 2,400 shares of the business's stock in a transaction that occurred on Thursday, May 1st. The shares were sold at an average price of $520.00, for a total value of $1,248,000.00. Following the transaction, the director now owns 6,371 shares of the company's stock, valued at $3,312,920. This represents a 27.36% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 33,044 shares of company stock valued at $17,070,433. Corporate insiders own 0.70% of the company's stock.

Intuitive Surgical Trading Up 4.6%

Shares of NASDAQ ISRG traded up $24.92 during trading hours on Monday, reaching $561.43. The stock had a trading volume of 2,036,477 shares, compared to its average volume of 1,633,304. The firm has a market cap of $201.23 billion, a price-to-earnings ratio of 87.59, a PEG ratio of 5.85 and a beta of 1.70. The firm has a 50-day moving average of $500.93 and a 200-day moving average of $535.03. Intuitive Surgical, Inc. has a fifty-two week low of $379.67 and a fifty-two week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, beating analysts' consensus estimates of $1.71 by $0.10. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. The firm had revenue of $2.25 billion during the quarter, compared to the consensus estimate of $2.19 billion. During the same quarter last year, the firm earned $1.50 earnings per share. On average, equities analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Wall Street Analysts Forecast Growth

ISRG has been the topic of a number of recent analyst reports. Jefferies Financial Group lifted their target price on Intuitive Surgical from $475.00 to $575.00 in a research report on Monday, January 27th. Erste Group Bank lowered shares of Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a research note on Monday, March 17th. Bernstein Bank upped their target price on Intuitive Surgical from $655.00 to $700.00 and gave the stock an "overweight" rating in a research note on Monday, January 27th. Royal Bank of Canada decreased their price objective on Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating on the stock in a report on Wednesday, April 23rd. Finally, BTIG Research set a $560.00 price objective on shares of Intuitive Surgical and gave the stock a "buy" rating in a report on Monday, April 14th. Five research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average target price of $598.95.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.